Abstract OT-09-06: Phase II neoadjuvant study of GDC-9545 + palbociclib (palbo) vs anastrozole (A) + palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2- eBC)
Year: 2021
Type: conference-abstract
Source: Cancer Research
Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Samsung Medical Center, Institut Català d'Oncologia, GEICAM – Spanish Breast Cancer Group, F. Hoffmann-La Roche AG, Genentech, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3131880140